North Carolina Community Health Center Association

North Carolina Community Health Center Association, doing business as North Carolina Primary Health Care Association Inc., is a tax-exempt nonprofit entity based in Raleigh, North Carolina, that functions as the HRSA-designated primary care association for North Carolina and operates as a federal grant recipient (68% of awards) and subrecipient across health research, rural health network development, and behavioral health service expansion programs. The organization holds one federal contract prime award—a $1.667 million definitive contract from the Food and Drug Administration for rural clinical investigator readiness under a Broad Agency Announcement focused on modernizing product development and regulatory science, running through May 2029 under NAICS 541715 and PSC AJ11.

The organization's customer concentration runs heavily through the Department of Health and Human Services and its component agencies. The Health Resources and Services Administration accounts for 9 awards across federal grant recipients and subrecipients; the Centers for Disease Control and Prevention holds 5 awards; and the FDA accounts for the single measurable-value prime contract at $1.667 million. The top five HHS-component customers cover 79% of recent award count. Grant work emphasizes rural health networks, behavioral health integration, and clinical research participation equity. Representative prime grants include a Rural Health Network Development Planning Grant from the Federal Office of Rural Health Policy (awarded July 2023, completed June 2024) to coordinate behavioral health and primary care services across four rural North Carolina counties, a three-year cooperative agreement from the FDA's Office of the Commissioner (awarded June 2023, completing May 2026) focused on improving multicultural engagement in clinical trials through federally qualified health centers and community health worker programs, and a Health Center Controlled Network project grant from the HIV/AIDS Bureau (awarded August 2022, completing July 2028).

As a subrecipient, the organization receives pass-through awards from the North Carolina Department of Health and Human Services across diabetes intervention implementation, opioid use disorder medication-assisted treatment expansion, and COVID-19 testing mitigation in rural community health centers. Recent sub-awards include three rounds of diabetes intervention contracts (June 2025, July 2025, and July 2026) and an opioid use disorder expansion contract (June 2025). Activity has trended toward concentration in recent years—three awards in 2023 and 2025 each, with one in 2024 and two in 2026. Combined obligations ($75.2 million) vastly exceed combined potential value ($1.7 million), indicating that prior-year awards have executed and obligated funds substantially across the portfolio's lifetime. Two awards face ultimate completion within the next twenty-four months.